메뉴 건너뛰기




Volumn 5, Issue 11, 2000, Pages 913-927

Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TENASCIN; TENASCIN X; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN B; VASCULOTROPIN RECEPTOR;

EID: 0034508480     PISSN: 13569597     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2443.2000.00376.x     Document Type: Article
Times cited : (65)

References (30)
  • 2
    • 0030932842 scopus 로고    scopus 로고
    • Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1
    • (1997) J. Biol. Chem. , vol.272 , pp. 10382-10388
    • Barleon, B.1    Totzke, F.2    Herzog, C.3
  • 19
    • 0031816864 scopus 로고    scopus 로고
    • What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis?
    • (1998) Am. J. Pathol. , vol.153 , pp. 11-16
    • Nicosia, R.F.1
  • 21
    • 0032553299 scopus 로고    scopus 로고
    • A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain
    • (1998) J. Biol. Chem. , vol.273 , pp. 31273-31282
    • Ogawa, S.1    Oku, A.2    Sawano, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.